Designed Ankyrin Repeat Protein (DARPin) Neutralizers of TcdB from Clostridium difficile Ribotype 027
出版年份 2019 全文链接
标题
Designed Ankyrin Repeat Protein (DARPin) Neutralizers of TcdB from Clostridium difficile Ribotype 027
作者
关键词
-
出版物
mSphere
Volume 4, Issue 5, Pages -
出版商
American Society for Microbiology
发表日期
2019-10-01
DOI
10.1128/msphere.00596-19
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Selection and characterization of ultrahigh potency designed ankyrin repeat protein inhibitors of C. difficile toxin B
- (2019) Rudo Simeon et al. PLOS BIOLOGY
- Toxin B Variants from Clostridium difficile Strains VPI 10463 and NAP1/027 Share Similar Substrate Profile and Cellular Intoxication Kinetics but Use Different Host Cell Entry Factors
- (2019) Diana López-Ureña et al. Toxins
- Structural basis for recognition of frizzled proteins byClostridium difficiletoxin B
- (2018) Peng Chen et al. SCIENCE
- The Conserved Cys-2232 in Clostridioides difficile Toxin B Modulates Receptor Binding
- (2018) Soo-Young Chung et al. Frontiers in Microbiology
- Functional defects inClostridium difficileTcdB toxin uptake identify CSPG4 receptor-binding determinants
- (2017) Pulkit Gupta et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Design and characterization of MP0250, a tri-specific anti-HGF/anti-VEGF DARPin® drug candidate
- (2017) H. Kaspar Binz et al. mAbs
- Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection
- (2017) Mark H. Wilcox et al. NEW ENGLAND JOURNAL OF MEDICINE
- Frizzled proteins are colonic epithelial receptors for C. difficile toxin B
- (2016) Liang Tao et al. NATURE
- Clostridium difficile infection
- (2016) Wiep Klaas Smits et al. Nature Reviews Disease Primers
- Administration of Spores of NontoxigenicClostridium difficileStrain M3 for Prevention of RecurrentC difficileInfection
- (2015) Dale N. Gerding et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Burden of Clostridium difficile Infection in the United States
- (2015) Fernanda C. Lessa et al. NEW ENGLAND JOURNAL OF MEDICINE
- Identification of an epithelial cell receptor responsible forClostridium difficileTcdB-induced cytotoxicity
- (2015) Michelle E. LaFrance et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Frizzled-7 as a Potential Therapeutic Target in Colorectal Cancer
- (2015) Koji Ueno et al. NEOPLASIA
- Broad Coverage of Genetically Diverse Strains of Clostridium difficile by Actoxumab and Bezlotoxumab Predicted byIn VitroNeutralization and Epitope Modeling
- (2014) Lorraine D. Hernandez et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Chondroitin sulfate proteoglycan 4 functions as the cellular receptor for Clostridium difficile toxin B
- (2014) Pengfei Yuan et al. CELL RESEARCH
- NAP1 Strain Type Predicts Outcomes From Clostridium difficile Infection
- (2014) I. See et al. CLINICAL INFECTIOUS DISEASES
- Mechanism of Action and Epitopes ofClostridium difficileToxin B-neutralizing Antibody Bezlotoxumab Revealed by X-ray Crystallography
- (2014) Peter Orth et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Designed Ankyrin Repeat Proteins: A New Approach to Mimic Complex Antigens for Diagnostic Purposes?
- (2014) Stefanie Hausammann et al. PLoS One
- Protective Efficacy Induced by Recombinant Clostridium difficile Toxin Fragments
- (2013) Rosanna Leuzzi et al. INFECTION AND IMMUNITY
- Clostridium difficile 027/BI/NAP1 Encodes a Hypertoxic and Antigenically Variable Form of TcdB
- (2013) Jordi M. Lanis et al. PLoS Pathogens
- Efficacy, Safety, and Tolerability of Herpes Zoster Vaccine in Persons Aged 50-59 Years
- (2012) K. E. Schmader et al. CLINICAL INFECTIOUS DISEASES
- A Chimeric Toxin Vaccine Protects against Primary and Recurrent Clostridium difficile Infection
- (2012) Haiying Wang et al. INFECTION AND IMMUNITY
- Antibody Against TcdB, but Not TcdA, Prevents Development of Gastrointestinal and Systemic Clostridium difficile Disease
- (2012) Jennifer Steele et al. JOURNAL OF INFECTIOUS DISEASES
- Protective antibody responses againstClostridium difficileelicited by a DNA vaccine expressing the enzymatic domain of toxin B
- (2012) Ke Jin et al. Human Vaccines & Immunotherapeutics
- Bispecific Designed Ankyrin Repeat Proteins (DARPins) Targeting Epidermal Growth Factor Receptor Inhibit A431 Cell Proliferation and Receptor Recycling
- (2011) Ykelien L. Boersma et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The role of toxin A and toxin B in the virulence of Clostridium difficile
- (2011) Glen P. Carter et al. TRENDS IN MICROBIOLOGY
- Human Hypervirulent Clostridium difficile Strains Exhibit Increased Sporulation as Well as Robust Toxin Production
- (2010) M. Merrigan et al. JOURNAL OF BACTERIOLOGY
- A review of mortality due to Clostridium difficile infection
- (2010) J.A. Karas et al. JOURNAL OF INFECTION
- The role of toxin A and toxin B in Clostridium difficile infection
- (2010) Sarah A. Kuehne et al. NATURE
- A DNA vaccine targeting the receptor-binding domain of Clostridium difficile toxin A
- (2009) David F. Gardiner et al. VACCINE
- Comparative genome and phenotypic analysis of Clostridium difficile 027 strains provides insight into the evolution of a hypervirulent bacterium
- (2009) Richard A Stabler et al. GENOME BIOLOGY
- Expression of recombinant Clostridium difficile toxin A and B in Bacillus megaterium
- (2008) Guilin Yang et al. BMC MICROBIOLOGY
- The Case for Vancomycin as the Preferred Drug for Treatment ofClostridium difficileInfection
- (2008) John G. Bartlett CLINICAL INFECTIOUS DISEASES
- Increased Sporulation Rate of Epidemic Clostridium difficile Type 027/NAP1
- (2008) T. Akerlund et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Efficient Selection of DARPins with Sub-nanomolar Affinities using SRP Phage Display
- (2008) Daniel Steiner et al. JOURNAL OF MOLECULAR BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search